Invention Grant
US08592590B2 Tetrahydrotriazolopyridine compounds as selective MGLU5 receptor potentiators useful for the treatment of schizophrenia
有权
四氢三唑并吡啶化合物作为治疗精神分裂症的选择性MGLU5受体增强剂
- Patent Title: Tetrahydrotriazolopyridine compounds as selective MGLU5 receptor potentiators useful for the treatment of schizophrenia
- Patent Title (中): 四氢三唑并吡啶化合物作为治疗精神分裂症的选择性MGLU5受体增强剂
-
Application No.: US13515407Application Date: 2010-12-21
-
Publication No.: US08592590B2Publication Date: 2013-11-26
- Inventor: Lourdes Prieto , Lorena Taboada Martinez
- Applicant: Lourdes Prieto , Lorena Taboada Martinez
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Mark A Winter
- Priority: EP09382309 20091229
- International Application: PCT/US2010/061406 WO 20101221
- International Announcement: WO2011/082010 WO 20110707
- Main IPC: C07D513/02
- IPC: C07D513/02 ; A01N43/42
Abstract:
The present invention provides certain tetrahydrotriazolopyridine derivatives, pharmaceutical compositions thereof, methods of using the same and processes for preparing the same. Formula (I) wherein R1 is hydrogen, fluoro, chloro, or methyl; and R2 is C4-CS branched alkyl.
Public/Granted literature
Information query
